Durvalumab vs Sertraline

## Durvalumab vs Sertraline: Overview

This comparison examines the pharmacological differences between **Durvalumab** and **Sertraline**.

## Mechanism of Action

**Durvalumab**: Human IgG1 kappa anti-PD-L1 monoclonal antibody blocking PD-L1 binding to PD-1 and CD80.

**Sertraline**: Selective serotonin reuptake inhibitor (SSRI).

## Pharmacokinetics

**Half-life**: Durvalumab — 17 days; Sertraline — 26 hours.

## Chemical Properties

**Molecular Formula**: Durvalumab — N/A; Sertraline — C17H17Cl2N.

**Molecular Weight**: Durvalumab — N/A; Sertraline — 306.2290 g/mol.

**Type**: Durvalumab — Antibody; Sertraline — Small molecule.